Acuity Brands, Inc. (AYI - Free Report) is slated to announce third-quarter fiscal 2020 results on Jun 30, before the opening bell.
In the last reported quarter, its adjusted earnings missed the Zacks Consensus Estimate by 2.1% but revenues beat the same by 3.4%. The top and bottom lines declined 3.5% and 7.5%, respectively, from the prior-year quarter. The downside was caused by a 7% decline in volumes, higher acquisition-related costs, increased professional fees and high variable incentive compensations.
Trend in Estimate Revision
For the quarter to be reported, the Zacks Consensus Estimate for earnings per share has been downwardly revised to $1.29 over the past seven days. The estimated figure indicates a decrease of 49% from $2.53 per share reported in the year-ago quarter. The consensus mark for revenues is pegged at $783.13 million, suggesting a 17.4% decrease from the year-ago reported figure of $947.6 million.
Acuity Brands Inc Price and EPS Surprise
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Acuity Brands, Inc. (AYI - Free Report) is slated to announce third-quarter fiscal 2020 results on Jun 30, before the opening bell.
In the last reported quarter, its adjusted earnings missed the Zacks Consensus Estimate by 2.1% but revenues beat the same by 3.4%. The top and bottom lines declined 3.5% and 7.5%, respectively, from the prior-year quarter. The downside was caused by a 7% decline in volumes, higher acquisition-related costs, increased professional fees and high variable incentive compensations.
Trend in Estimate Revision
For the quarter to be reported, the Zacks Consensus Estimate for earnings per share has been downwardly revised to $1.29 over the past seven days. The estimated figure indicates a decrease of 49% from $2.53 per share reported in the year-ago quarter. The consensus mark for revenues is pegged at $783.13 million, suggesting a 17.4% decrease from the year-ago reported figure of $947.6 million.
Acuity Brands Inc Price and EPS Surprise
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on WY - FREE
Get the latest research report on PCH - FREE
Get the latest research report on AYI - FREE